Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up

BACKGROUND: Subclinical thyrotoxicosis (SCT) is associated with significant morbidity and mortality, specifically increased risk of atrial fibrillation and cardiovascular death. The management is ill-defined due to the scarcity of randomised controlled studies. Some clinicians recommend radioiodine...

Descripción completa

Detalles Bibliográficos
Autores principales: Phowira, Jason, Coffey, Katherine L., Bartholomew, Peter H., Vennart, Nicholas, Moreira, Matheus, Emerson, Hannah, Kennedy, David, Weaver, Jolanta U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965555/
https://www.ncbi.nlm.nih.gov/pubmed/35370990
http://dx.doi.org/10.3389/fendo.2022.843857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965555/
https://www.ncbi.nlm.nih.gov/pubmed/35370990
http://dx.doi.org/10.3389/fendo.2022.843857

Ejemplares similares